Indeed, TRAP1 silencing increases mitochondrial respiration without affecting glycolysis in ovarian cancer [82], and the isogenic cell lines of cisplatin-resistant ovarian carcinoma derived from patients after chemotherapy showed lower levels of TRAP1, increased oxygen consumption, and reduced glycolysis compared with the sensitive cell lines derived from the same patients before chemotherapy. This evidence concerns the gene TRAP1 and ovarian cancer.